Mucoepid ermoid carcinoma of the nasal cavity is rare. We report the case of a 57-year-old man who was evaluated fo r a rapidly enlarging subcutaneous mass on the nasal bridge. The tumor was diagnosed as a mucoepidermoid carcinoma. The patient underwent extensive surgical resection and postoperative radiotherapy, but 5 months later he required orbital exenteration fo r persistellt disease. Despite these radical measures, the patient died with persistent disease 9 months following the initial evaluation. The aggressive behavio r of this tumor highlights the need fo r physicians to be aware ofthe diffe rential diagnosis, symptoms, and signs of neoplasm s that originate in the nasal cavity so that prompt treatment can be instituted.
Introduction
Mucoepidermoid carcin oma occurs most often in the major salivary glands, the minor salivary glands of the oral cavity and pharynx, and the lacrimal glands . Only rarely does it arise in the respir atory tract (i.e., the laryn x, trache a, and bronchi) or the sinonasal cavities.' According to co mbined reports of four large series of major and minor salivary gland tumors, sinonasal mucoep idermoid carcinoma accounts for 0.6% of all salivary tumors and 4.8 % of all mucoepidermoid carc inomas." To our knowledge, onl y 38 cases of sinonasa l mucoepidermoid carcinoma have been previously repo rted in the Englishlanguage literature. ' When these tumors do occur in the sinonasal tract, the most common site is the maxillary antrum; other sites, in order of decreasing incidence, include the nasal cavi ty, nasopharynx, and ethmoid sinuses . This pattern most likely refle cts the relative distribution of minor salivary gland s in this area of the upper aerodigestive tract. In this article, we describe a new case of mucoepidermoid carcinoma of the nasal cavit y, and we review the diagno sis, histopathologic features, and treatment option s regarding this aggressive disease.
Case report
An otherwise healthy 57-year-old white man was referred to the Miami Veterans Affairs Medical Center for evaluation of a rapidly enlarging subcutaneous mass over his upper nasal dorsum . He complained that he had experienced seve re facial pain and intermittent epistaxis durin g the precedin g 9 month s. His history was significant for tobacco, marijuana, and cocaine use.
Facial examination revealed that the nasal bridge had been widened by a subcutaneous mass that extended from the glabellar area to the rhinion (figure I). At the area of the left medi al canthus, the mass had eroded the bone and extruded through the skin. Intranasal examination detected a large septal perforation with friable borders and the presence of soft tissue that filled the upper nasal cavi ty. The patient 's extraocular muscle movements and visual acuity were intact bilaterall y. Neck examination identifi ed no adenopathy or masses. Computed tomography (CT) and magnetic resonance imaging (MRI) were performed to evaluate the extent oflocal disease and possible intracr anial extension. Although there was no evidence of intracranial extension on these images, the mass exte nded to the cribriform plate.
A biopsy specimen of the mass was consistent with high-grade mucoepid ermoid carcino ma. The patient underwent anterior craniofacia l resection, total rhinectomy, medial maxillectomi es, and resec tions of the ethmoid and sphenoid sinuses. All tissue margins obtained intraoperatively were negative for tumor on frozen-section analysis.
The patient' s recovery was uneventful , and he was started on postoperative radiotherapy. Five months after the completion of radiothe rapy, he co mplained ofincreasing facial and eye pain . Persistent disease was found in the right infraorbital region and right eye. After providing adequate coun seling and obtaining informed consent , we performed a right orbital exenteration with a complete maxillectomy. Intraoperatively, microscopic mucoepidermoid carcinoma was identified in the pericranial flap that had been used to reconstruct the cribriform plate during the first resection. After extensive discussions with the patient, his family, and the multidiscipl inary treatment team , no further therapeutic intervention was planned . The patient died from meningitis 9 months following his initial evaluation.
Discussion
Malignant tumors of the nasal cavity are rare. The differential diagnosis of cancer in this area includes squamous cell carcinoma, adenocarcinoma, undifferentiated carci-noma, melanoma, lymphoma, and, rarely, mucoepidermoid carcinoma. Muir and Nectoux studied tumor registry data on 1, I30 male and 691 female patients who had cancer of the nose , nasal cavity , middle ear, or accessory sinuses and found a predominance of squamous cell carcinomas (60 % of cases). ' Other common findings were undifferentiated carcinomas (l 0.2 %) and adenocarcinomas (9.4 %). Melanomas and lymphomas accounted for 4.9 and 3% of cases , respectively. However, in more recent studies, lower rates of squamous cell carcinoma have been reported. For example, Haraguchi et al reviewed 60 cases of cancer of the nasal cavity and found that squamous cell carcinoma was still the most common type , but it had accounted for only 25% of cases; melanoma and lymphoma accounted for 23% each, and mucoepidermoid carcinoma accounted for 1.7%.4
Sinonasal tract adenomatous tumors have been presumed to arise from submucosal mucoserous glands. However, a study of the mucosal origin of 107 sinonasal tract adenomatous tumors by Gnepp and Heffner found that most (including 83% of mucoepidermoid carcinomas) originated in the surface mucosa.' The mucoepidermoid carcinomas in their series were frequently accompanied by abnormal (dyspl astic) surface mucosa adjacent to the tumor. These findings suggest that mucoepidermoid carcinoma of the sino nasal tract, like squamous cell carcinoma, can be preceded by mucosal dysplasia or carcinoma in situ .
Although moid carcinoma have been identified, minor trauma and chronic irritation have been implicated in the etiology of sinonasal tract cancers in general. Reports of other causes have been sporadic; these causes include vitamin A deficiency, occupational factors (e .g., working with wood dust, industrial toxins, nickel, chrome , leather, textiles, and clothing), and radiation exposure. There is no persuasive evidence that cigarette smoking is an etiologic factor .in sinonasal carcinoma. Symptoms and physical findings in patients with mucoepidermoid carcinoma of the sinonasal tract can include nasal obstruction, epistaxis, facial pain, diplopia, and/or a subcutaneous mass if the tumor has eroded bone and invaded the subcutis. Imaging studies , including CT, should be part of the early clinical management to determine if a neoplasm is present. When a mass is identified, MRI is essential for assessing possible intracranial extension.
The histopathologic picture of mucoepidermoid carcinoma includes varying proportions of cystic and solid epithelial elements made up of different proportions of mucous, epidermoid, intermediate, and clear cells (figure 2). Intermediate cells usually predominate; they are round to ovoid and smaller than epidermoid (squamous) cells. Mucous cells can be sparse or inconspicuous, but their presence is required for a diagnosis; special stains for mucin-such as mucicarmine or alcian blue (figure 3)might be needed to identify them . Clear cells often contain glycogen and are probably altered epidermoid cells .
Tumor grading is based on morphologic and cyto logic features . The five main grading parameters are (1) the proportions of cystic and solid elements, (2) the presence or absence of neural invasion, (3) the presence or absence of necrosis, (4) the mitotic rate, and (5) the presence or absence of cellular anaplasia. A quantitative system assigns a point value to each parameter, and the total score determines the tumor grade (low, intermediate, or high) . 6 We found no reported series of cases of mucoepidermoid carcinoma of the nasal cavity in which the treatment strategy and clinical outcomes could be assessed. However, this information can be extracted from reports that described mucoepidermoid carcinoma in all sites in the tumors . In addition to high tumor grade, other predictive factors that have been associated with poor 5-year survival include bone invasion, age beyond 60 years, pain, positive cervical nodes, and facial nerve palsy. In a series of 60 patients with mucoepidermoid carcinoma of the head and neck, Healey et al described five patients who had high-grade mucoepidermoid carcinoma of the maxi llary antrum; four of the five died of local disease despite radical surgery and radiotherapy. 8 The findings described in these reports imply that treatment of mucoepidermoid carcinoma of the nasal cavity should be based on the tumor grade , the extent of tumor invasion, and the medical condition of the patient. Surgical resection alone has been advocated for lowgrade mucoepidermoid carcinoma. For intermediate and high-grade tumors, however, complete resection and postoperative radiation are recommended. Clinical nodal disease should be treated with appropriate neck dissection and postoperative radiotherapy if indicated. Because of the small number of reported cases of mucoepidermoid carcinoma of the nasal cavity and the paucity of data on the use of chemotherapy in these patients, the role of chemotherapy as an adjunct to loca l treatment cannot currently be assessed.
In summary, mucoepidermoid carcinoma of the nasal cavity is rare. Affected patients can manifest the signs and symptoms typica l of chronic sinusitis, such as nasa l obstruct ion and epistaxi s. CT should be part of the early management ofthese patients to look for a possible tumor. Altho ugh the patholog ic diagnosis of low-and intermediate-grade mucoepidermoid carcinoma is relatively straightforward, high-grade mucoepidermoid carcinoma can be diffic ult to differentiate from squamous cell carcinoma and therefore might require specia l histologic stains to demonstrate the mucous component. Low-grade mucoepidermoid carcinoma can often be treated with surgical resection alone, depending on the exten t of the disease. Combined surgery and postoperative radiotherapy has been advocated for intermediate-and high-grade tumors. However, even with aggressive measures, high-grade mucoepidermoid carcinoma of the nasal cavity is associated with poor surviva l. Therefore, early treatment is of the utmost importance.
